Latest Breaking News On - Enrico bonadio - Page 6 : comparemela.com

The COVID-19 pandemic, and the race to make vaccines and other useful technologies more accessible to people around the world, has once again highlighted the tension between intellectual property rights and the promotion of public health. There is no doubt that the monopolies offered by exclusive rights such as patents are necessary to incentivise pharmaceutical companies to invest huge resources and develop useful drugs. These rights help manufacturers recoup those investments. It is not only drugs and medical equipment like ventilators which are needed, but also essential technologies such as copyright-protected virus-tracing software. Yet, as companies which own intellectual property have a monopoly over their products, they are able to raise prices. This may – in the case of anti-COVID technologies – mean less access to life-saving treatments. Imposing high prices would also be unfair considering that over US$12 billion of public funding has been poured into the research an

United kingdomEl salvadorRepublic ofSouth africaSouth africanDhanaym cadillo chandlerEnrico bonadioBoris johnsonPacific partnershipUniversity of londonGlobal vaccine allianceUniversity of turkuCoalition for epidemic preparedness innovationsWorld health organisationConversation weeklyProgressive agreement